vs

Side-by-side financial comparison of ARGENX SE (ARGX) and Raymond James Financial (RJF). Click either name above to swap in a different company.

Raymond James Financial is the larger business by last-quarter revenue ($3.9B vs $2.5B, roughly 1.6× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 14.1%, a 21.4% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 13.0%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Raymond James Financial, Inc. is an American multinational independent investment bank and financial services company providing financial services to individuals, corporations, and municipalities through its subsidiary companies that engage primarily in investment and financial planning, in addition to investment banking and asset management. The company is headquartered in St. Petersburg, Florida.

ARGX vs RJF — Head-to-Head

Bigger by revenue
RJF
RJF
1.6× larger
RJF
$3.9B
$2.5B
ARGX
Growing faster (revenue YoY)
ARGX
ARGX
+70.2% gap
ARGX
83.2%
13.0%
RJF
Higher net margin
ARGX
ARGX
21.4% more per $
ARGX
35.5%
14.1%
RJF

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ARGX
ARGX
RJF
RJF
Revenue
$2.5B
$3.9B
Net Profit
$877.2M
$544.0M
Gross Margin
89.5%
Operating Margin
28.9%
Net Margin
35.5%
14.1%
Revenue YoY
83.2%
13.0%
Net Profit YoY
1.3%
10.0%
EPS (diluted)
$13.25
$2.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
RJF
RJF
Q1 26
$3.9B
Q4 25
$2.5B
$4.2B
Q3 25
$4.2B
Q2 25
$1.8B
$3.8B
Q1 25
$3.8B
Q4 24
$1.4B
$4.0B
Q3 24
$4.0B
Q2 24
$901.9M
$3.8B
Net Profit
ARGX
ARGX
RJF
RJF
Q1 26
$544.0M
Q4 25
$877.2M
$563.0M
Q3 25
$604.0M
Q2 25
$414.8M
$436.0M
Q1 25
$495.0M
Q4 24
$865.6M
$600.0M
Q3 24
$602.0M
Q2 24
$-32.5M
$492.0M
Gross Margin
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
89.5%
Q3 25
Q2 25
89.2%
Q1 25
Q4 24
90.2%
Q3 24
Q2 24
89.4%
Operating Margin
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
28.9%
Q3 25
Q2 25
19.2%
14.7%
Q1 25
17.5%
Q4 24
8.7%
18.6%
Q3 24
Q2 24
-15.4%
17.1%
Net Margin
ARGX
ARGX
RJF
RJF
Q1 26
14.1%
Q4 25
35.5%
13.5%
Q3 25
14.4%
Q2 25
23.4%
11.3%
Q1 25
12.9%
Q4 24
64.1%
14.9%
Q3 24
15.0%
Q2 24
-3.6%
13.1%
EPS (diluted)
ARGX
ARGX
RJF
RJF
Q1 26
$2.83
Q4 25
$13.25
$2.79
Q3 25
$2.96
Q2 25
$6.32
$2.12
Q1 25
$2.36
Q4 24
$13.33
$2.86
Q3 24
$2.85
Q2 24
$-0.55
$2.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
RJF
RJF
Cash + ST InvestmentsLiquidity on hand
$3.5B
$5.4B
Total DebtLower is stronger
Stockholders' EquityBook value
$7.3B
$52.0M
Total Assets
$8.7B
$91.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
RJF
RJF
Q1 26
$5.4B
Q4 25
$3.5B
$9.9B
Q3 25
$11.4B
Q2 25
$2.1B
$9.2B
Q1 25
$9.7B
Q4 24
$1.5B
$10.0B
Q3 24
$11.0B
Q2 24
$1.4B
$9.1B
Total Debt
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$11.0M
Stockholders' Equity
ARGX
ARGX
RJF
RJF
Q1 26
$52.0M
Q4 25
$7.3B
$12.6B
Q3 25
$12.5B
Q2 25
$6.1B
$12.3B
Q1 25
$12.2B
Q4 24
$5.5B
$11.9B
Q3 24
$11.7B
Q2 24
$4.3B
$11.2B
Total Assets
ARGX
ARGX
RJF
RJF
Q1 26
$91.9B
Q4 25
$8.7B
$88.8B
Q3 25
$88.2B
Q2 25
$7.2B
$84.8B
Q1 25
$83.1B
Q4 24
$6.2B
$82.3B
Q3 24
$83.0B
Q2 24
$4.8B
$80.6B
Debt / Equity
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
RJF
RJF
Operating Cash FlowLast quarter
$323.3M
Free Cash FlowOCF − Capex
$322.4M
FCF MarginFCF / Revenue
13.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.37×
TTM Free Cash FlowTrailing 4 quarters
$594.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
$323.3M
$-10.0M
Q3 25
$796.0M
Q2 25
$361.8M
$691.0M
Q1 25
$117.0M
Q4 24
$41.9M
$830.0M
Q3 24
$510.0M
Q2 24
$-124.7M
$711.0M
Free Cash Flow
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
$322.4M
$-56.0M
Q3 25
$752.0M
Q2 25
$356.6M
$634.0M
Q1 25
$71.0M
Q4 24
$40.9M
$789.0M
Q3 24
$460.0M
Q2 24
$-125.5M
$655.0M
FCF Margin
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
13.0%
-1.3%
Q3 25
17.9%
Q2 25
20.1%
16.5%
Q1 25
1.8%
Q4 24
3.0%
19.6%
Q3 24
11.5%
Q2 24
-13.9%
17.4%
Capex Intensity
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
0.0%
1.1%
Q3 25
1.1%
Q2 25
0.3%
1.5%
Q1 25
1.2%
Q4 24
0.1%
1.0%
Q3 24
1.2%
Q2 24
0.1%
1.5%
Cash Conversion
ARGX
ARGX
RJF
RJF
Q1 26
Q4 25
0.37×
-0.02×
Q3 25
1.32×
Q2 25
0.87×
1.58×
Q1 25
0.24×
Q4 24
0.05×
1.38×
Q3 24
0.85×
Q2 24
1.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

RJF
RJF

Private Client Group$2.8B73%
Bank$486.0M13%
Capital Markets$464.0M12%
Other$99.0M3%

Related Comparisons